Octave Life Sciences

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 14, 2019	D&D Pharmatech	$137.1M Series B	Octave Life Sciences, Smilegate Investment	InterVest, LB Investment, Magna Investment
Jul 18, 2018	Neuraly	$36.0M Series A	D&D Pharmatech	Dongkoo Bio&Pharma, Geon Investment, Junghee Lim, LB Investment, Keele Park, Phillip Jung, John Ku

Total Raised

N/A

Valuation

N/A